Earnings Call · Q2 FY2025·2025-07-29

Q2 25EPS +51.61%·Rev n/aQ1 25EPS +38.89%·Rev n/aQ4 24EPS +16.43%·Rev n/aQ3 24EPS +46.88%·Rev n/a⚠ consensus missing

Teladoc Health, Inc. TDOC

Michael Minchak — Head of Investor Relations

Charles Divita — CHIEF EXECUTIVE OFFICER

Mala Murthy — CHIEF FINANCIAL OFFICER

−8.2%1d on move date−7.9% vs SPY3d−12.1%5d−15.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TDOC calls or request research access.

More TDOC calls Browse calls Request research access